Helping biotech and pharmaceutical businesses achieve successful pricing and market access

WHAT WE DO

Maximise your product opportunities through market access excellence

GLOBAL EXPERTS

RJW&partners provides pricing and market access consulting services for biotech and pharmaceutical companies worldwide.

Our team of dedicated, highly qualified consultants works in the UK and internationally, with a global network of trusted partners.

QUICK LINKS TO SERVICES
WHY RJW&partners?

Flexible. Responsive. Collaborative.

And five other attributes that make us stand out.

Asset 1.1.png

KNOWLEDGE:
We speak the language of product development

Asset 2.1.png

ACTION:

Practical solutions to complex challenges

Asset 3.1.png

CLARITY:

Highlighting the granularity within a bigger picture

Asset 4.1.png

LEADERSHIP:
Senior team engagement in project delivery

Asset 1.png

PARTNERSHIP:
We work with you as partners, not vendors

HOW WE WORK

We collaborate to achieve your patient access goals

One size does not fit all. We tailor our work to your company, your people and your products. Each project requires a unique combination of fresh ideas and tried-and-tested methodologies.


Our collaborative approach gives you the opportunity to explore issues and strategic assumptions. It also prepares you for challenging questions from regulators, payers and investors.

Asset 2.png
WHO WE ARE
 

Highly experienced market access consultants

RJW&partners’ senior managers have worked in the pharmaceutical industry, healthcare and government. Our consultants have advised on pricing and market access strategy for most of today’s leading pharmaceutical brands across all therapy areas.

 

We continue to work with national and commercial health systems across developed and emerging markets, bringing to your project a unique mix of expertise and hands-on experience making things happen.

RJW got up to speed very quickly - not many briefings were necessary; the execution was extremely swift and at the same time in-depth. RJW worked very independently without much coaching necessary from our side, which exceeded our expectations."

Global Health Economist

READ THE CASE STUDIES HERE
NEWS & INSIGHTS

Stay up-to-date with our latest news, views, and sector insights